A detailed history of State Of Wisconsin Investment Board transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, State Of Wisconsin Investment Board holds 94,761 shares of SUPN stock, worth $3.37 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
94,761
Previous 100,961 6.14%
Holding current value
$3.37 Million
Previous $2.7 Million 9.41%
% of portfolio
0.01%
Previous 0.01%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$25.77 - $35.16 $159,774 - $217,991
-6,200 Reduced 6.14%
94,761 $2.95 Million
Q2 2024

Aug 14, 2024

BUY
$25.99 - $33.85 $148,298 - $193,148
5,706 Added 5.99%
100,961 $2.7 Million
Q1 2024

May 14, 2024

BUY
$27.11 - $35.17 $435,115 - $564,478
16,050 Added 20.26%
95,255 $3.25 Million
Q4 2023

Feb 12, 2024

BUY
$22.72 - $29.68 $798,903 - $1.04 Million
35,163 Added 79.84%
79,205 $2.29 Million
Q3 2023

Nov 14, 2023

SELL
$27.57 - $32.91 $164,069 - $195,847
-5,951 Reduced 11.9%
44,042 $1.21 Million
Q2 2023

Aug 14, 2023

BUY
$29.91 - $38.73 $50,308 - $65,143
1,682 Added 3.48%
49,993 $1.5 Million
Q1 2023

May 15, 2023

SELL
$34.93 - $42.03 $187,224 - $225,280
-5,360 Reduced 9.99%
48,311 $1.75 Million
Q4 2022

Feb 14, 2023

SELL
$31.09 - $37.88 $14,923 - $18,182
-480 Reduced 0.89%
53,671 $1.91 Million
Q3 2022

Nov 14, 2022

SELL
$28.79 - $35.41 $102,060 - $125,528
-3,545 Reduced 6.14%
54,151 $1.83 Million
Q2 2022

Aug 15, 2022

SELL
$25.33 - $34.25 $301,528 - $407,712
-11,904 Reduced 17.1%
57,696 $1.67 Million
Q4 2020

Feb 03, 2021

SELL
$17.7 - $25.81 $153,990 - $224,547
-8,700 Reduced 11.11%
69,600 $1.75 Million
Q3 2020

Nov 16, 2020

SELL
$20.2 - $25.05 $2,020 - $2,505
-100 Reduced 0.13%
78,300 $1.63 Million
Q2 2020

Aug 12, 2020

SELL
$17.09 - $24.89 $63,233 - $92,093
-3,700 Reduced 4.51%
78,400 $1.86 Million
Q1 2020

May 06, 2020

BUY
$14.45 - $24.69 $118,490 - $202,458
8,200 Added 11.1%
82,100 $1.48 Million
Q3 2019

Nov 12, 2019

BUY
$25.47 - $33.37 $1.29 Million - $1.69 Million
50,700 Added 218.53%
73,900 $2.03 Million
Q2 2019

Aug 14, 2019

SELL
$29.96 - $38.87 $1.26 Million - $1.63 Million
-42,000 Reduced 64.42%
23,200 $768,000
Q1 2019

May 13, 2019

BUY
$32.77 - $41.99 $488,273 - $625,651
14,900 Added 29.62%
65,200 $2.29 Million
Q4 2018

Feb 11, 2019

BUY
$30.84 - $49.51 $12,336 - $19,804
400 Added 0.8%
50,300 $1.67 Million
Q2 2018

Aug 03, 2018

BUY
$44.1 - $59.85 $105,840 - $143,640
2,400 Added 5.05%
49,900 $2.99 Million
Q4 2017

Feb 08, 2018

BUY
$36.4 - $42.6 $418,600 - $489,900
11,500 Added 31.94%
47,500 $1.89 Million
Q3 2017

Nov 01, 2017

BUY
$36.75 - $49.65 $1.32 Million - $1.79 Million
36,000
36,000 $1.44 Million

Others Institutions Holding SUPN

About SUPERNUS PHARMACEUTICALS, INC.


  • Ticker SUPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,495,300
  • Market Cap $1.9B
  • Description
  • Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...
More about SUPN
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.